Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБУ Научный центр психического здоровья РАМН, Москва
Список исп. литературыСкрыть список 1. Beasley CM Jr, Stauffer VL, Liu-Seifert H et al. All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis. J Clin Psychopharmacol 2007; 27 (3): 252–8. 2. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiat 2003; 60 (6): 553–64. 3. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br Med J 2000; 321: 1371–6. 4. Haro JM, Suarez D, Novick D et al. SOHO Study Group. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results. Eur Neuropsychopharmacol 2007; 17 (4): 235–44. 5. Herz MI, Glazer WM, Mostert MA et al. Intermittent vs maintenance medication in schizophrenia: two-year results. Arch Gen Psychiat 1991; 48: 333–9. 6. Leucht S, Corves C, Arbter D et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. The Lancet 2009; 373 (9657): 31–41. 7. Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–23. 8. Liu-Seifert H, Adams DH, Kinon BJ. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Med 2005; 23 (3): 21. 9. Swartz M, Zhu B, Ascher-Svanum H et al. Time to all-cause discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Schizophr Bull 2005; 31 (2): 551. 10. Zhao F, Ascher-Svanum H, Mitchell CP et al. Increased time to all-cause antipsychotic trial discontinuation is associated with better schizophrenia treatment outcomes. Schizophr Bull 2005; 31 (2): 508.